SCHEMBL17354952

SCHEMBL17354952

O=c1[nH]nc(NN2CCCCCC2)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 4/20 0.46
AURKA O14965 1/20 0.46
KDM1A O60341 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
KMT2A Q03164 2/20 0.45
HIF1A Q16665 1/20 0.45
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ROCK2 O75116 2/20 0.42
ROCK1 Q13464 2/20 0.42
MAPK8 P45983 1/20 0.41
MAPK10 P53779 1/20 0.41
PRMT5 O14744 1/20 0.41
CYP1A2 P05177 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 2/20 0.40
NPY1R P25929 1/20 0.40
NPY2R P49146 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17354955 1.00 AURKB (0.46) AURKBAURKAKDM1ASMN1; SMN2KMT2A
SCHEMBL6502392 0.80 MAPK10 (0.52) AURKAKDM1AMAPK8MAPK10KDM4E
SCHEMBL13153524 0.71 KDM4E (0.60) AURKBAURKAATMNPSR1ROCK2
SCHEMBL2511703 0.69 AURKB (0.59) AURKBAURKAATMNPSR1ROCK1
SCHEMBL17444762 0.68 SMN1; SMN2 (0.52) SMN1; SMN2KMT2AHIF1APRMT5KDM4E
SCHEMBL1225418 0.68 ROCK2 (0.73) ATMNPSR1ROCK2ROCK1KDM4E
SCHEMBL12786062 0.66 HSD17B10 (0.45) AURKBAURKAATMNPSR1MAPK8
SCHEMBL9584160 0.66 AURKB (0.51) AURKBAURKASMN1; SMN2KMT2AHIF1A
SCHEMBL28655449 0.66 AURKB (0.55) AURKBAURKAKDM1ASMN1; SMN2KMT2A
SCHEMBL12846288 0.65 ROCK2 (0.42) AURKBAURKASMN1; SMN2KMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771175-B1 PHTHALAZINE DERIVATIVES AS PARP INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-23 EP disclosed